RHYTHM PHARMACEUTICALS, INC. Annual Nonoperating Income (Expense) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Rhythm Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2015 to 2023.
  • Rhythm Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$100K, a 163% decline year-over-year.
  • Rhythm Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $7.24M, a 34390% increase year-over-year.
  • Rhythm Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $243K.
  • Rhythm Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.96M, a 102% decline from 2021.
  • Rhythm Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $100M, a 3795% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $243K +$2.21M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$1.96M -$102M -102% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $100M +$97.9M +3795% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $2.58M -$2.69M -51.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $5.27M +$918K +21.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $4.35M +$5.65M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$1.3M -$1.33M -4030% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $33K +$533K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-08
2015 -$500K Jan 1, 2015 Dec 31, 2015 8-K 2018-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.